Clinical Evaluation of Two Daily Disposable Contact Lenses

Inclusion criteria

• The subject must be between 18 and 45 years of age (inclusive)with no presbyopic add.
• The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form. This should be recorded on the Case Report Form (CRF).
• The subject must be willing to wear the study lenses for at least 8 hours per day, at least 6 days between visits.
• The subject must be a current successful spherical soft contact lens wearer in both eyes.
• The subject must appear willing and able to adhere to the instructions set forth in this clinical protocol.
• The subject's subjective refraction must result in a vertex corrected spherical contact lens prescription in the range of -1.00D to -6.00D (inclusive) in each eye.
• The subject's refractive astigmatism must be less than or equal to -0.75D in both eyes.
• The subject must have corrective visual acuity of 6/9 (20/30) or better in each eye.
• The subject must require a visual correction in both eyes (no monofit or monovision allowed).

Exclusion criteria

• Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
• Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, corneal staining, or infiltrates or any other abnormalities of the cornea which would contraindicate contact lens wear.
• Clinically significant (Grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
• Any ocular infection.
• Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• Currently pregnant or lactating (subject who become pregnant during the study will be discontinued).
• Diabetes.
• Infectious diseases (e.g. hepatitis, tuberculosis) or an immunosuppressive disease (e.g. HIV).
• Amblyopia
• Evidence of lid abnormality or infection (including blepharitis/meibomitis)
• Conjunctival abnormality or infection.
• Any active ocular disease.
• Employee or family member of the staff of the investigational site.